QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
NASDAQ:MIST

Milestone Pharmaceuticals (MIST) Price Target & Analyst Ratings

$2.98
-0.12 (-3.87%)
(As of 10/2/2023 ET)
Compare
Today's Range
$2.95
$3.12
50-Day Range
$2.68
$3.47
52-Week Range
$2.68
$9.73
Volume
28,184 shs
Average Volume
126,239 shs
Market Capitalization
$99.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00

Milestone Pharmaceuticals Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 3 Analyst Ratings

Consensus Analyst Price Target

$14.00
369.80% Upside
High Prediction$25.00
Average Prediction$14.00
Low Prediction$4.00
TypeCurrent
10/2/22 to 10/2/23
1 Month Ago
9/2/22 to 9/2/23
3 Months Ago
7/4/22 to 7/4/23
1 Year Ago
10/2/21 to 10/2/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$14.00$14.00$14.00$10.00
Predicted Upside369.80% Upside302.68% Upside276.01% Upside37.17% Upside
Get Milestone Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MIST and its competitors with MarketBeat's FREE daily newsletter.


MIST Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MIST Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Milestone Pharmaceuticals Stock vs. The Competition

TypeMilestone PharmaceuticalsMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.65
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside362.05% Upside893.33% Upside698.25% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/14/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$25.00+709.06%
6/20/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$8.00 ➝ $4.00+14.29%
4/12/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$16.00 ➝ $13.00+238.54%
(Data available from 10/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












MIST Price Target - Frequently Asked Questions

What is Milestone Pharmaceuticals's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Milestone Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for MIST. The average twelve-month price prediction for Milestone Pharmaceuticals is $14.00 with a high price target of $25.00 and a low price target of $4.00. Learn more on MIST's analyst rating history.

Do Wall Street analysts like Milestone Pharmaceuticals more than its competitors?

Analysts like Milestone Pharmaceuticals more than other Medical companies. The consensus rating score for Milestone Pharmaceuticals is 2.67 while the average consensus rating score for medical companies is 2.66. Learn more on how MIST compares to other companies.

Does Milestone Pharmaceuticals's stock price have much upside?

According to analysts, Milestone Pharmaceuticals's stock has a predicted upside of 302.68% based on their 12-month price targets.

What analysts cover Milestone Pharmaceuticals?

Milestone Pharmaceuticals has been rated by HC Wainwright in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:MIST) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -